Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) — Capital Reinvestment Ratio

Latest as of December 2023: 4.22x

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (688212) has a Capital Reinvestment Ratio of 4.22x as of December 2023, meaning it reinvests 4% of its operating cash flow (CN¥37.41 Million) in capital expenditures (CN¥157.83 Million). See net asset quality index of Shanghai Aohua Photoelectricity Endoscop to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

4.22x
Capex / Operating Cash Flow

Operating Cash Flow

CN¥37.41 Million
CNY

Capital Expenditures

CN¥157.83 Million
CNY

Data as of

Dec 2023
Most recent filing

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A Capital Reinvestment Ratio (2019–2023)

This chart tracks Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A's Capital Reinvestment Ratio across 4 annual periods. Check how aggressively does Shanghai Aohua Photoelectricity Endoscop reinvest cash to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A (2019–2023)

Year-by-year Capital Reinvestment Ratio for Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A from 2019 to 2023. For live market cap and broader valuation context, see Shanghai Aohua Photoelectricity Endoscop stock valuation.

Year Reinvestment Ratio Operating CF (CNY) Capital Expenditures YoY Change
2023 4.22x CN¥37.41 Million CN¥157.83 Million ▲ +204.7%
2021 1.38x CN¥66.15 Million CN¥91.61 Million ▲ +60.2%
2020 0.86x CN¥71.52 Million CN¥61.83 Million ▼ -37.4%
2019 1.38x CN¥47.39 Million CN¥65.50 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow